$25.92
Insights on Healthstream Inc
Revenue is up for the last 11 quarters, 64.09M → 72.76M (in $), with an average increase of 1.3% per quarter
Netprofit is up for the last 3 quarters, 3.86M → 5.22M (in $), with an average increase of 14.0% per quarter
In the last 1 year, Healthequity Inc has given 48.1% return, outperforming this stock by 45.8%
0.98%
Downside
Day's Volatility :2.64%
Upside
1.67%
21.45%
Downside
52 Weeks Volatility :30.01%
Upside
10.9%
Period | Healthstream Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -3.79% | 1.7% | 0.0% |
6 Months | 2.45% | 11.3% | 0.0% |
1 Year | 2.33% | 5.4% | 1.3% |
3 Years | 16.55% | 13.9% | -22.1% |
Market Capitalization | 802.8M |
Book Value | $11.38 |
Dividend Share | 0.103 |
Dividend Yield | 0.42% |
Earnings Per Share (EPS) | 0.5 |
PE Ratio | 52.82 |
PEG Ratio | 3.97 |
Wall Street Target Price | 31.67 |
Profit Margin | 6.3% |
Operating Margin TTM | 7.82% |
Return On Assets TTM | 2.32% |
Return On Equity TTM | 5.23% |
Revenue TTM | 282.9M |
Revenue Per Share TTM | 9.27 |
Quarterly Revenue Growth YOY | 5.5% |
Gross Profit TTM | 175.7M |
EBITDA | 38.3M |
Diluted Eps TTM | 0.5 |
Quarterly Earnings Growth YOY | 0.98 |
EPS Estimate Current Year | 0.53 |
EPS Estimate Next Year | 0.59 |
EPS Estimate Current Quarter | 0.11 |
EPS Estimate Next Quarter | 0.12 |
What analysts predicted
Upside of 22.18%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 231.6M | ↓ 6.48% |
Net Income | 32.2M | ↑ 222.04% |
Net Profit Margin | 13.91% | ↑ 9.87% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 254.1M | ↑ 9.71% |
Net Income | 15.8M | ↓ 51.05% |
Net Profit Margin | 6.21% | ↓ 7.7% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 244.8M | ↓ 3.65% |
Net Income | 14.1M | ↓ 10.65% |
Net Profit Margin | 5.76% | ↓ 0.45% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 256.7M | ↑ 4.85% |
Net Income | 5.8M | ↓ 58.52% |
Net Profit Margin | 2.28% | ↓ 3.48% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 266.8M | ↑ 3.94% |
Net Income | 12.1M | ↑ 106.86% |
Net Profit Margin | 4.53% | ↑ 2.25% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 279.1M | ↑ 4.59% |
Net Income | 15.2M | ↑ 25.82% |
Net Profit Margin | 5.45% | ↑ 0.92% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 68.5M | ↑ 1.86% |
Net Income | 2.4M | ↓ 33.2% |
Net Profit Margin | 3.57% | ↓ 1.88% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 68.9M | ↑ 0.6% |
Net Income | 2.6M | ↑ 7.1% |
Net Profit Margin | 3.8% | ↑ 0.23% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 69.2M | ↑ 0.37% |
Net Income | 4.1M | ↑ 57.57% |
Net Profit Margin | 5.97% | ↑ 2.17% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 70.3M | ↑ 1.65% |
Net Income | 3.9M | ↓ 6.44% |
Net Profit Margin | 5.5% | ↓ 0.47% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 70.6M | ↑ 0.34% |
Net Income | 4.6M | ↑ 18.7% |
Net Profit Margin | 6.5% | ↑ 1.0% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 72.8M | ↑ 3.09% |
Net Income | 5.2M | ↑ 13.88% |
Net Profit Margin | 7.18% | ↑ 0.68% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 440.2M | ↑ 7.08% |
Total Liabilities | 121.2M | ↑ 9.3% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 489.5M | ↑ 11.22% |
Total Liabilities | 151.4M | ↑ 24.88% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 500.3M | ↑ 2.2% |
Total Liabilities | 166.3M | ↑ 9.83% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 486.8M | ↓ 2.71% |
Total Liabilities | 147.7M | ↓ 11.14% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 497.7M | ↑ 2.26% |
Total Liabilities | 163.7M | ↑ 10.79% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 499.9M | ↑ 0.44% |
Total Liabilities | 159.2M | ↓ 2.74% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 497.7M | ↑ 3.44% |
Total Liabilities | 163.7M | ↑ 8.46% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 503.2M | ↑ 1.09% |
Total Liabilities | 167.1M | ↑ 2.1% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 493.5M | ↓ 1.92% |
Total Liabilities | 152.9M | ↓ 8.54% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 498.1M | ↑ 0.93% |
Total Liabilities | 155.8M | ↑ 1.93% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 499.9M | ↑ 0.38% |
Total Liabilities | 159.2M | ↑ 2.17% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 511.6M | ↑ 2.33% |
Total Liabilities | 166.8M | ↑ 4.75% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 43.2M | ↓ 7.42% |
Investing Cash Flow | 36.6M | ↓ 415.73% |
Financing Cash Flow | -30.3M | ↓ 3025200.0% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 65.7M | ↑ 51.82% |
Investing Cash Flow | -67.5M | ↓ 284.7% |
Financing Cash Flow | -916.0K | ↓ 96.97% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 35.9M | ↓ 45.36% |
Investing Cash Flow | -110.4M | ↑ 63.51% |
Financing Cash Flow | -20.5M | ↑ 2137.34% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 42.4M | ↑ 18.15% |
Investing Cash Flow | -25.7M | ↓ 76.7% |
Financing Cash Flow | -6.2M | ↓ 69.7% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 51.2M | ↑ 20.77% |
Investing Cash Flow | -28.4M | ↑ 10.36% |
Financing Cash Flow | -23.7M | ↑ 281.74% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 8.1M | ↓ 46.3% |
Investing Cash Flow | -10.4M | ↑ 156.04% |
Financing Cash Flow | -47.0K | ↑ 135.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 20.5M | ↑ 153.34% |
Investing Cash Flow | -16.9M | ↑ 63.25% |
Financing Cash Flow | -791.0K | ↑ 1582.98% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.9M | ↓ 75.91% |
Investing Cash Flow | -26.4M | ↑ 55.94% |
Financing Cash Flow | -1.5M | ↑ 94.69% |
Sell
Neutral
Buy
Healthstream Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Healthstream Inc | -0.54% | 2.45% | 2.33% | 16.55% | 0.12% |
Solventum Corp | -8.05% | -8.05% | -8.05% | -8.05% | -8.05% |
Veeva Systems Inc. | -12.6% | 2.95% | 12.12% | -29.27% | 46.25% |
Ge Healthcare Technologies Inc. | -1.77% | 34.43% | 7.87% | 43.36% | 43.36% |
Healthequity Inc | -0.23% | 9.82% | 48.12% | 3.76% | 13.86% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Healthstream Inc | 52.82 | 52.82 | 3.97 | 0.53 | 0.05 | 0.02 | 0.0 | 11.38 |
Solventum Corp | NA | NA | NA | 0.0 | 0.12 | 0.08 | NA | NA |
Veeva Systems Inc. | 62.45 | 62.45 | 1.35 | 4.76 | 0.13 | 0.05 | NA | 28.8 |
Ge Healthcare Technologies Inc. | 28.44 | 28.44 | 20.11 | 4.3 | 0.19 | 0.06 | 0.0 | 15.67 |
Healthequity Inc | 124.8 | 124.8 | 2.29 | 2.19 | 0.03 | 0.03 | NA | 23.63 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Healthstream Inc | Buy | $802.8M | 0.12% | 52.82 | 6.3% |
Solventum Corp | NA | $11.7B | -8.05% | NA | 16.42% |
Veeva Systems Inc. | Buy | $32.4B | 46.25% | 62.45 | 22.24% |
Ge Healthcare Technologies Inc. | Buy | $39.4B | 43.36% | 28.44 | 8.02% |
Healthequity Inc | Buy | $6.9B | 13.86% | 124.8 | 5.57% |
BlackRock Inc
Vanguard Group Inc
Dimensional Fund Advisors, Inc.
State Street Corporation
Punch & Associates Inv Mgmt Inc
Renaissance Technologies Corp
thousands of healthcare providers, including half of u.s. hospitals, have chosen healthstream (nasdaq: hstm) as their partner for improving clinical and business outcomes. in this new era of healthcare reform, meaningful use, and value-based purchasing, hundreds of leading organizations each year are switching to healthstream to elevate the role of learning and development in addressing these challenges. our vision healthstream’s vision is to improve the quality of healthcare by assessing and developing the people who deliver care.
Organization | Healthstream Inc |
Employees | 1079 |
CEO | Mr. Robert A. Frist Jr. |
Industry | Technology Services |